Close Menu

NEW YORK (GenomeWeb) – Resolution Bioscience said today that it is collaborating with Janssen to develop its Resolution HRD liquid biopsy test as a companion diagnostic for niraparib, a PARP inhibitor being investigated to treat patients with metastatic castration-resistant prostate cancer.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.